logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
18/09/2025
Lyft rose 13%, hitting a closing high not seen since May 2022.
Latest
2 m ago
The Central Bank of Brazil will keep the benchmark interest rate unchanged at 15.00%.
3 m ago
Saudi Press Agency: Saudi Arabia and Pakistan sign a mutual defense agreement.
7 m ago
Market news: JPMorgan Chase CEO Jamie Dimon told Republican members of the U.S. Senate during a luncheon on September 17th that tariffs are causing uncertainty.
8 m ago
On September 17th, after hours, Novo Nordisk's stock surged by over 2%. According to media reports, Novo Nordisk has submitted a new drug application to the US Food and Drug Administration (FDA) for review before the end of the year. Novo Nordisk's oral version weight loss drug Wegovy showed similar effectiveness to the injectable version in weight loss trials. In a newly published study, Novo Nordisk's oral semaglutide 25 mg (Wegovy tablets*) achieved a 16.6% weight loss in obese individuals. The oral version of semaglutide 25 mg showed improvements in daily physical activity and cardiovascular risk factors. The safety and tolerability profile of the oral semaglutide version is consistent with the injectable version of Wegovy.
17 m ago
Cryptocurrency exchange Bullish surged more than 3% after hours, announcing its first financial report after going public. In the 25th fiscal quarter of 2025, the sales of digital assets were $58.6 billion, compared to $49.6 billion in the same period last year; net profit was $108.3 million.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.